Noncovalent Bile Acid Oligomers as Facial Amphiphilic Antimicrobials
- 19 December 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 39 (1) , 495-506
Abstract
New antimicrobial agents are needed to address the ever-growing risk of bacterial resistance, particularly for methicillin- and vancomycin-resistant Staphylococcus aureus (S. aureus). Here, we report a class of bile acid oligomers as facial amphiphilic antimicrobials, which are noncovalently fabricated by cholic acid (CA) and deoxycholic acid (DCA) with polyamines (e.g., diamines, diethylenetriamine, spermidine, and spermine). The antibacterial activities of these bile acid oligomers (CA/polyamines and DCA/polyamines) against S. aureus become stronger with increasing the amine group numbers of polyamines without obviously enhanced cytotoxicity and skin irritation. DCA/spermine, entirely composed of natural products, exhibits the best antibacterial activity but the lowest cytotoxicity and the weakest skin irritation. All CA/polyamines and DCA/polyamines form well-ordered ribbon-like aggregates, collecting numerous facial amphiphilic structures to significantly enhance the interactions with bacterial membranes. In particular, the biogenic polyamines with more than two amine groups provide extra positively charged sites, hence facilitating the binding of bile acid oligomers to the negatively charged outer membrane of the bacteria via electrostatic interaction. This in turn promotes more oligomeric bile acid units that can be inserted into the membrane through hydrophobic interaction between bile acids and lipid domains. The noncovalently constructed and separable amphiphilic antimicrobials can avoid the long-term coexistence of microorganisms and antibacterial molecules in different acting modes. Therefore, the noncovalent bile acid oligomers, especially those with higher oligomerization degrees, can be a potential approach to effectively enhance antibacterial activity, improve environmental friendliness, and reduce bacterial drug resistance.Keywords
Funding Information
- Ministry of Science and Technology of Thailand (2021YFA0716700)
- National Natural Science Foundation of China (21811530002, 21972149, 21988102)
This publication has 63 references indexed in Scilit:
- Biodegradable nanostructures with selective lysis of microbial membranesNature Chemistry, 2011
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Improved antimicrobial peptides based on acyl-lysine oligomersNature Biotechnology, 2007
- Antimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNature Biotechnology, 2006
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Antimicrobial peptides of multicellular organismsNature, 2002
- Non-Leaky Vesicle Fusion and Enhanced Cell Transfection Using a Cationic Facial AmphiphileJournal of the American Chemical Society, 2000
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Cardiolipins and biomembrane functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- The enterohepatic circulation of bile acids as they relate to lipid disorders.Journal of Clinical Pathology, 1973